Program 2: Cancer Imaging Program (CIP)
项目 2:癌症影像项目 (CIP)
基本信息
- 批准号:9315739
- 负责人:
- 金额:$ 0.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:Advanced DevelopmentAnimalsAppointmentArizonaBiological MarkersCancer BiologyCancer CenterCancer Center Support GrantCancer InterventionCancer ModelChemicalsClinicClinicalClinical TrialsCollaborationsContrast MediaCritiquesCyclotronsDataDevelopmentDiagnosisDiagnostic ProcedureDiagnostic radiologic examinationDoctor of PhilosophyEnvironmentFatty acid glycerol estersFosteringFoundationsFundingFutureGamma RaysGlioblastomaGoalsGrantHealthHealthcare SystemsHypoxiaImageImaging DeviceImaging technologyIntervention StudiesJointsLaboratoriesLeadLeadershipMagnetic Resonance ImagingMalignant NeoplasmsMammographic DensityManuscriptsMentorsMethodologyMissionModelingMonitorOvarian CarcinomaPatientsPeer ReviewPerformancePositron-Emission TomographyPreventionProcessPublished CommentRadialRadiochemistryResearchResearch PersonnelResourcesRiskScienceScreening for cancerSecureSourceTechnologyTestingTrainingTraining ProgramsTranslatingTranslationsUltrasonographyUniversitiesValidationWaterbasebioimagingcancer diagnosiscancer imagingcancer preventioncancer therapyclinical applicationclinical developmentclinical research sitecollegecostdesignimage processingimaging modalityimaging programimaging systeminnovationliver tumor ablationmathematical modelmembermolecular imagingnanoDropletnew technologynovelnovel diagnosticsnovel strategiesnuclear imagingoptical imagingpreclinical trialpreventprogramsprototypeskillsspectroscopic imagingtissue oxygenationtranslational pipelinetumor
项目摘要
Project Summary / Abstract: Cancer Imaging Program (CIP)
The scientific goal of the Cancer Imaging Program (CIP) is to develop and apply imaging technologies and
imaging methods for cancer prevention and intervention studies. Members of the CIP are working at the
forefront of the field and have been eminently successful in utilizing the theoretical underpinnings of imaging
science to advance new imaging technologies for a wide array of critical cancer applications. Program activities
are organized under three major themes: Theme 1) Advancement of major biomedical imaging technologies
for cancer; Theme 2) Molecular imaging and the development of advanced contrast agents, including analysis
of their mechanisms; and Theme 3) Advancement of theoretical image science related to cancer. The CIP
provides a dynamic cancer-focused environment that fosters inter-programmatic collaborations with a robust
translational pipeline that facilitates entry of research applications into investigator-initiated clinical trials (IITs).
CIP has two Specific Aims: Aim 1) To promote advances in imaging science and technology and their
application in the context of cancer biology, early cancer detection, development and monitoring of cancer
therapies, and cancer prevention studies; Aim 2) To promote translation of the science into clinical trials and
development and testing of new technologies in the clinic through investigator-initiated clinical trials (IITs) and
coordinated validation at other clinical sites. CIP leadership, in cooperation with the UACC and University of
Arizona (UA) leadership, is instrumental in securing sources for pilot funding for prototype testing/development
and in providing access to unique laboratory and clinical methodologies to aid researchers who are involved in
the discovery and development of new diagnostic methods and new anticancer therapies. The CIP builds on
the UA's excellence in imaging science. The CIP has 31 Members, from 10 different departments, with
complementary, specialized skills drawn from multiple colleges and departments across the UA. Joint
appointments in multiple departments and membership in Graduate Interdisciplinary Programs provide the
dynamic networks of interaction required for highly innovative research. The effective integration of the diverse
Membership into cancer imaging research, combined with funded mentoring and training programs, have
resulted in the sustained, broad-based development of novel approaches to cancer diagnosis/therapy and
significant high-impact contributions. CIP Members have contributed to 249 cancer-relevant manuscripts, of
which 33% were intra-programmatic and 31% were inter-programmatic. As of September 1, 2015, the CIP
Program secured more than $7.5M in total annual grant dollars, with $3M of that from the NCI and $4M in
other peer-reviewed funding. Major funding held by Program Members includes a Center Grant
(P41EB002035) that supports UA's “Center for Gamma Ray Imaging” and a Training grant (T32EB000809)
entitled “Biomedical Imaging and Spectroscopy.”
项目概要/摘要:癌症成像计划(CIP)
癌症成像计划(CIP)的科学目标是开发和应用成像技术,
用于癌症预防和干预研究的成像方法。CIP的成员正在
该领域的最前沿,并在利用成像的理论基础方面取得了显著成功
科学,以推进新的成像技术,为广泛的关键癌症应用。方案活动
主题1)主要生物医学成像技术的发展
主题2)分子成像和先进造影剂的开发,包括分析
主题3)与癌症相关的理论影像科学的进展。了CIP
提供了一个动态的以癌症为重点的环境,促进了项目间的合作,
翻译管道,促进研究申请进入制药商发起的临床试验(IIT)。
CIP有两个具体目标:目标1)促进成像科学和技术的进步,
在癌症生物学、早期癌症检测、癌症发展和监测方面的应用
目的2)促进科学转化为临床试验,
通过制药商发起的临床试验(IIT)在临床上开发和测试新技术,
在其他临床研究中心协调验证。CIP领导,与UACC和University of
亚利桑那州(UA)的领导层,在确保原型测试/开发的试点资金来源方面发挥了重要作用
并提供独特的实验室和临床方法,以帮助研究人员参与
发现和开发新的诊断方法和新的抗癌疗法。CIP建立在
美国在成像科学方面的卓越成就总督察有31名成员,来自10个不同的部门,
互补的,专业的技能来自多个学院和部门在整个UA。联合
在多个部门的任命和研究生跨学科计划的成员提供了
高度创新研究所需的动态互动网络。有效整合不同的
癌症成像研究的会员资格,结合资助的指导和培训计划,
导致癌症诊断/治疗新方法的持续、广泛发展,
重要的高影响力贡献。CIP成员为249份癌症相关手稿做出了贡献,
其中33%是项目内的,31%是项目间的。截至2015年9月1日,CIP
该计划获得了超过750万美元的年度赠款,其中300万美元来自NCI,400万美元来自
其他同行评审资金。计划成员持有的主要资金包括中心赠款
(P41 EB 002035),支持UA的“伽马射线成像中心”和培训补助金(T32 EB 000809)
题为“生物医学成像和光谱学”
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Kehlet Barton其他文献
Jennifer Kehlet Barton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Kehlet Barton', 18)}}的其他基金
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
使用基于血液和成像的生物标志物检测卵巢癌
- 批准号:
10598251 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
使用基于血液和成像的生物标志物检测卵巢癌
- 批准号:
10737827 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
使用基于血液和成像的生物标志物检测卵巢癌
- 批准号:
10544781 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
使用基于血液和成像的生物标志物检测卵巢癌
- 批准号:
10314537 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes
用于输卵管微创成像的先进输卵管镜
- 批准号:
9754821 - 财政年份:2016
- 资助金额:
$ 0.59万 - 项目类别:
Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes
用于输卵管微创成像的先进输卵管镜
- 批准号:
9352340 - 财政年份:2016
- 资助金额:
$ 0.59万 - 项目类别:
Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes
用于输卵管微创成像的先进输卵管镜
- 批准号:
9175237 - 财政年份:2016
- 资助金额:
$ 0.59万 - 项目类别:
Validating a mouse model of ovarian cancer for early detection through imaging
验证卵巢癌小鼠模型以通过成像进行早期检测
- 批准号:
8902450 - 财政年份:2015
- 资助金额:
$ 0.59万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 0.59万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 0.59万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 0.59万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 0.59万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)